IDEXX Laboratories (IDXX) Revenue — Quarter Ended Mar 31, 2026
Revenue for the quarter ended March 31, 2026 increased compared to both the immediately preceding quarter and the same quarter one year earlier. The trend shows continued growth over recent quarters.
Key takeaway
Quarter ended Mar 31, 2026 · FY2026 Q1
Revenue for the quarter ended March 31, 2026 increased compared to both the immediately preceding quarter and the same quarter one year earlier. The trend shows continued growth over recent quarters.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$1.1B
Revenue reported for this quarter.
Quarter-over-quarter
+4.6%
Change from the immediately preceding quarter.
Year-over-year
+14.3%
Change from the comparable year-ago quarter.
Trailing four quarters
$4.4B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Jun 30, 2025 | $1.1B | +10.6% |
| Sep 30, 2025 | $1.1B | +13.3% |
| Dec 31, 2025 | $1.1B | +14.3% |
| Mar 31, 2026 | $1.1B | +14.3% |
Revenue performance
Reported revenue moved higher, reflecting an upward direction for the quarter.
Quarterly comparison
Revenue grew versus the immediately preceding quarter and also rose compared to the same quarter one year earlier. The sequential increase was more moderate than the year-over-year gain.
What to watch
The sequential revenue increase slowed compared with the year-over-year growth rate, warranting attention to the pace of expansion.